Urofollitropin is a purified form of follicle-stimulating hormone (FSH) used primarily in assisted reproductive technologies (ART) to stimulate follicular development in women undergoing treatments like in vitro fertilization (IVF). It is administered via subcutaneous or intramuscular injections and is closely monitored through ultrasound and serum estradiol levels to ensure proper ovarian response and to adjust dosages accordingly.
Recent updates highlight its usage protocols, emphasizing that the treatment typically starts on day 2 or 3 of the menstrual cycle with an initial dose of 225 units daily for the first five days. The dosage may then be adjusted based on the ovarian response observed through ultrasound and serum estradiol levels. The maximum daily dose recommended is 450 units, and the treatment duration should not exceed 12 days【Drugs.com】
There are several critical warnings and precautions associated with urofollitropin use. One of the primary concerns is the risk of ovarian hyperstimulation syndrome (OHSS), a potentially severe condition that can lead to significant abdominal pain, bloating, nausea, and, in extreme cases, more severe symptoms like thromboembolism and pulmonary issues. To mitigate this risk, careful monitoring and dosage adjustments are essential. Patients are also advised to avoid strenuous activities and sexual intercourse if the ovaries are significantly enlarged【Drugs.com】.
Urofollitropin is contraindicated in women with certain medical conditions, including primary ovarian failure, unexplained vaginal bleeding, tumors of the reproductive organs, and known hypersensitivity to the drug. It is also not recommended for use during pregnancy due to potential risks to the fetus, and breastfeeding mothers are advised against using it【Drugs.com】.
In terms of storage, urofollitropin should be kept at room temperature or refrigerated and protected from light. It must be used immediately after reconstitution, and any unused portions should be discarded appropriately【Drugs.com】.
Overall, while urofollitropin is a vital medication in the realm of fertility treatments, its use requires careful management and adherence to medical guidelines to ensure safety and effectiveness. Regular follow-ups with healthcare providers are crucial for monitoring the treatment's progress and managing any potential side effects or complications【Drugs.com】.